Tumour organoids are an in vitro patient-derived model type that has taken off in recent years. They are an important research tool, but what about as a precision medicine opportunity? Can we use tumour organoids to predict individual patient response to therapy?
This session will explore organoids as a research and clinical methodology. A/Prof Kylie Gorringe and Anshini Jain will look first at mucinous ovarian carcinoma as a cancer type where organoids are being used for a number of different research questions, including drug screening.
They will then share information about a trial in peritoneal cancers where the ultimate goal is to return results to clinicians in time to influence treatment. They will explore the potential but also the challenges of organoids in precision medicine.
This hybrid event is part of the VCCC Alliance Precision Oncology Forum series. These multi-disciplinary forums provide opportunities to discuss new research topics in Precision Oncology, as well as interesting and novel cases illustrating the clinical implications of molecular pathology and targeted therapies.
Cases are discussed on an individual, de-identified basis.
We are seeking clinical oncologists and scientists to join our Expert Reference Group for the VCCC Alliance Precision Oncology Forum. The VCCC Alliance Precision Oncology Forum is a multidisciplinary educational seminar series showcasing advances in precision oncology and providing attendees the opportunity to discuss and network. The Expert Reference Group will play a crucial role in guiding the educational focus of the Forum, promoting its relevance and impact.
Content warning: The VCCC Alliance Precision Oncology Forum is aimed primarily at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic.
